clinical pharmacology studies

Related by string. * clinicals . CLINICAL . Clinicals . Clinical : Phase III clinical trials . placebo controlled clinical trials . Phase III clinical . Phase 2b clinical / Pharmacology : clinical pharmacology clinical trials . pharmacology toxicology . preclinical pharmacology / STUDIES . Studies . Studie : Religious Studies . Forced Migration Studies . Graduate Studies * *

Related by context. Frequent words. (Click for all words.) 69 Phase 1b trial 69 Phase IIa trial 68 Phase 2a trial 68 phase IIa 68 phase IIb 67 Phase 2b study 66 clinical trials 66 Phase Ib 66 clinical trial 66 Phase 2b trial 65 Phase IIb trial 65 pharmacokinetic studies 65 Phase III trials 64 confirmatory Phase III 64 Phase IIb clinical 64 clinical 64 Phase 2a clinical 64 diabetic neuropathic pain 64 teduglutide 63 Phase IIb 63 tesmilifene 63 Phase 2b clinical 62 Phase III clinical 62 prospective observational 62 Phase IIa clinical 62 Icatibant 62 Phase III clinical trials 62 Cethrin 62 placebo controlled trials 62 alvimopan 62 methylnaltrexone 62 Phase 1a 62 Phase IIa 61 randomized Phase III 61 Phase IIa clinical trials 61 ISIS # 61 Chrysalin 61 Ostarine 61 dose cohorts 61 Phase 1b 61 PROMACTA 61 lupus nephritis 61 dose escalation 61 Phase Ia 61 Phase 2a 60 multicenter clinical 60 PXD# 60 placebo controlled studies 60 CoFactor 60 pivotal Phase III 60 multicenter study 60 PREOS 60 Phase 2b 60 MBP# [001] 60 active comparator 60 DSMB 60 Amigal 60 PROPEL trial 60 COPAXONE R 60 Ilaris 60 HuMax CD# 60 ALTU 60 PRX # 60 Neuradiab 60 axitinib 60 randomized clinical trials 60 Bronchitol 59 pharmacodynamics 59 HCV infected 59 pharmacokinetic 59 decitabine 59 Phase III 59 Viprinex 59 AZX# 59 warfarin therapy 59 Phenoptin 59 confirmatory Phase 3 59 Phase 1b clinical 59 MOZOBIL 59 Phase III pivotal 59 BCX# 59 NUVIGIL 59 COPAXONE ® 59 EORTC 59 talactoferrin 59 elagolix 59 Locteron 59 LymphoStat B 59 daclizumab 59 denufosol 59 sapacitabine 59 ADHF 58 nab paclitaxel 58 SUTENT 58 mipomersen 58 secondary efficacy endpoints 58 blinatumomab 58 HGS ETR1 58 ofatumumab 58 ozarelix 58 ocrelizumab

Back to home page